Skip to content

XIENCE XPEDITION 1074300-28Recalls & reported problems

Abbott Vascular Inc. · XIENCE Xpedition Everolimus Eluting Coronary Stent System 3.00 mm x 28 mm / Rapid-Exchange · Class 3 · Implant

All models of XIENCE XPEDITION (41)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08717648162367), received between Nov 21, 2016 and Nov 21, 2016 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Stenosis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 21, 2016Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6) 2013 ONE 3.0X28 XIENCE XPEDITION STENT WAS IMPLANTED IN THE MID LEFT ANTERIOR DESCENDING (LAD) CORONARY ARTERY. ON (B)(6) 2016 TARGET LESION REVASCULARIZATION WAS PERFORMED VIA PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY TO TREAT IN-STENT RESTENOSIS. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Stenosis

    MAUDE report 6118140 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page